diacerein has been researched along with Cardiac Remodeling, Ventricular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, G; Liang, G; Liang, S; Luo, W; Sun, J; Wang, M; Yu, T; Zou, C | 1 |
| de Carvalho, DD; de Oliveira, PP; de Souza Vilarinho, KA; do Carmo, HR; Lima, F; Petrucci, O; Reichert, K; Saad, MJ; Sposito, AC; Torina, AG | 1 |
2 other study(ies) available for diacerein and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Diacerein alleviates Ang II-induced cardiac inflammation and remodeling by inhibiting the MAPKs/c-Myc pathway.
Topics: Angiotensin II; Animals; Anthraquinones; Cardiomegaly; Cardiomyopathies; Fibrosis; Heart Failure; Hypertension; Inflammation; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; RNA; Ventricular Remodeling | 2022 |
Diacerein improves left ventricular remodeling and cardiac function by reducing the inflammatory response after myocardial infarction.
Topics: Animals; Anthraquinones; Anti-Inflammatory Agents; Caspase 3; Disease Models, Animal; Gene Expression Regulation; Myocardial Infarction; Rats; Rats, Wistar; Transcription Factor RelA; Ventricular Function, Left; Ventricular Remodeling | 2015 |